Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes

Immunology Letters
Mary Poupot, Jean-Jacques Fournié

Abstract

Various non-peptidic ligands which specifically activate most of circulating human Vgamma9/Vdelta2 T lymphocytes are now known. Most of these are so-called phosphoantigens and directly trigger the Vgamma9/Vdelta2 TCR expressing cells, without need for MHC-restricted presentation molecules. Although some potent phosphoantigens currently involved in clinical trials are chemically-synthesized molecules, most of the natural antigens were isolated from microbial cultures. The structures and biosynthesis of phosphoantigens are reviewed here and the possible physiological significance of their recognition by gammadelta T lymphocytes is discussed.

References

Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y TanakaC T Morita
Nov 1, 1993·The Biochemical Journal·D OstrovskyA Sviridov
May 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Y TanakaC T Morita
Jun 1, 1996·Research in Immunology·J J Fournié, M Bonneville
Oct 1, 1996·European Journal of Immunology·Y PoquetJ J Fournié
Jan 1, 1997·Immunology Today·G De Libero
Oct 1, 1996·Research in Immunology·Y PoquetJ J Fournié
Apr 1, 1997·Anti-cancer Drugs·S FischerD Kabelitz
Nov 5, 1997·Science·J C Sacchettini, C D Poulter
Mar 6, 1999·The New England Journal of Medicine·V KunzmannM Wilhelm
Nov 5, 1999·The Journal of Biological Chemistry·C BelmantJ J Fournié
Jan 6, 2000·Archives of Biochemistry and Biophysics·J D BergstromG Rodan
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·H LüttgenW Eisenreich
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E GattiI Mellman
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MuzioA Mantovani
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·F RohdichA Bacher
Sep 6, 2000·Molecular Microbiology·Y Boucher, W F Doolittle
Sep 7, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C BelmantJ J Fournié
Dec 16, 2000·Springer Seminars in Immunopathology·C T MoritaM B Brenner
Feb 15, 2001·Trends in Plant Science·W EisenreichA Bacher
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·K Y YangS Zhang
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AltincicekH Jomaa
Mar 30, 2001·Bioorganic & Medicinal Chemistry Letters·A ReichenbergH Jomaa
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·F MiyagawaN Minato

❮ Previous
Next ❯

Citations

Feb 8, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Eric Champagne
May 9, 2006·Current Opinion in Lipidology·Eric ChampagneRonald Barbaras
Sep 15, 2011·PloS One·Alessandra CiucciGiorgio Mancino
Oct 25, 2006·Journal of Clinical and Experimental Hematopathology : JCEH·Yoshimasa Tanaka
May 26, 2009·Immunology Letters·Ludovic MartinetJean-Jacques Fournié
Feb 13, 2007·Immunological Reviews·Aurélie ThedrezMarc Bonneville
Apr 25, 2007·Immunology Letters·Julie GertnerJean-Jacques Fournié
Mar 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jonathan FisherJohn Anderson
Feb 7, 2009·European Journal of Immunology·Ludovic MartinetRémy Poupot
Apr 13, 2007·European Journal of Immunology·Seth L BlumermanCynthia L Baldwin
Nov 18, 2014·Nature Reviews. Microbiology·Nancie M ArchinDavid M Margolis
Nov 16, 2019·The Journal of Experimental Medicine·Gerardo A Vitiello, George Miller
Feb 16, 2007·Angewandte Chemie·Laurent GriffeJean-Pierre Majoral
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aude-Hélène CapiettoJean-Jacques Fournié
Jun 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aude-Hélène CapiettoJean-Jacques Fournié
Oct 30, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natalia Soriano-SarabiaHolger Hackstein
Nov 26, 2013·European Journal of Immunology·Florencia SabbioneCarolina C Jancic
Nov 27, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caroline DuaultMary Poupot
Jul 13, 2018·Frontiers in Immunology·Jonathan Fisher, John Anderson
Aug 2, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Neil E McCarthyAndrew J Stagg
Oct 16, 2015·European Journal of Immunology·Marie TosoliniJean-Jacques Fournié
Sep 10, 2017·Immunology·Nadia Yasmín TowstykaCarolina Cristina Jancic
Feb 7, 2020·Science Translational Medicine·Anna Hammerich ThysenSusanne Brix
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sherri DudalVirginie Lafont
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeff HoldernessMark A Jutila
Jun 30, 2021·Cellular & Molecular Immunology·Chloé LaplagneMary Poupot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.